Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups

Abstract excerpt

BACKGROUND: The malignant childhood brain tumour, medulloblastoma, is classified clinically into molecular groups which guide therapy. DNA-methylation profiling is the current classification 'gold-standard', typically delivered 3-4 weeks post-surgery. Pre-surgery non-invasive diagnostics thus offer significant potential to improve early diagnosis and clinical management. Here, we determine tumour metabolite...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced MRI Techniques and Applications
• Share to Glioma Diagnosis and Treatment
• Share to Metabolomics and Mass Spectrometry Studies